These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2067769)

  • 21. Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour.
    Charoenvidhya D; Manotaya S
    J Med Assoc Thai; 2013 Apr; 96(4):395-8. PubMed ID: 23691692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia.
    Chissell S; Botha JH; Moodley J; McFadyen L
    S Afr Med J; 1994 Sep; 84(9):607-10. PubMed ID: 7839282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of preeclampsia, magnesium sulfate prophylaxis, and maternal weight on labor induction: a retrospective analysis.
    Park KH; Cho YK; Lee CM; Choi H; Kim BR; Lee HK
    Gynecol Obstet Invest; 2006; 61(1):40-4. PubMed ID: 16179789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion.
    Cruikshank DP; Pitkin RM; Donnelly E; Reynolds WA
    Obstet Gynecol; 1981 Oct; 58(4):430-4. PubMed ID: 7279337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnesium sulfate administered via continuous intravenous infusion in pediatric patients with refractory wheezing.
    Glover ML; Machado C; Totapally BR
    J Crit Care; 2002 Dec; 17(4):255-8. PubMed ID: 12501154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of magnesium sulfate on large cerebral artery blood flow in preeclampsia.
    Hatab MR; Zeeman GG; Twickler DM
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):187-92. PubMed ID: 16147821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of magnesium sulfate treatment on serum cardiac troponin I levels in preeclamptic women.
    Atalay C; Erden G; Turhan T; Yildiran G; Saraçoglu OF; Koca Y
    Acta Obstet Gynecol Scand; 2005 Jul; 84(7):617-21. PubMed ID: 15954868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat postpartum magnesium sulfate administration for seizure prophylaxis: is there a patient profile predictive of need for additional therapy?
    Isler CM; Barrilleaux PS; Rinehart BK; Magann EF; Martin JN
    J Matern Fetal Neonatal Med; 2002 Feb; 11(2):75-9. PubMed ID: 12375546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low dose ("Dhaka") magnesium sulphate regime for eclampsia.
    Begum R; Begum A; Johanson R; Ali MN; Akhter S
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):998-1002. PubMed ID: 11703195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension.
    Alexander JM; McIntire DD; Leveno KJ; Cunningham FG
    Obstet Gynecol; 2006 Oct; 108(4):826-32. PubMed ID: 17012442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservative management of eclampsia and severe pre-eclampsia--A Bangladesh experience.
    Begum MR; Akhter S; Begum A; Khatun M; Quadir E; Choudhury SB
    Medscape Womens Health; 2002 Jan; 7(1):1. PubMed ID: 11965219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate.
    Lurie S; Gur D; Sadan O; Glezerman M
    J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients.
    Kosasa TS; Busse R; Wahl N; Hirata G; Nakayama RT; Hale RW
    Obstet Gynecol; 1994 Sep; 84(3):369-73. PubMed ID: 8058233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment.
    Hallak M; Berry SM; Madincea F; Romero R; Evans MI; Cotton DB
    Obstet Gynecol; 1993 Feb; 81(2):185-8. PubMed ID: 8423946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between magnesium sulfate therapy and fetal heart rate variability.
    Atkinson MW; Belfort MA; Saade GR; Moise KJ
    Obstet Gynecol; 1994 Jun; 83(6):967-70. PubMed ID: 8190442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Audit can ensure the safe and effective introduction of seizure prophylaxis with magnesium sulphate in obstetric practice.
    Owen P
    Health Bull (Edinb); 2000 Sep; 58(5):414-7. PubMed ID: 12813796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia.
    Bhattacharjee N; Saha SP; Ganguly RP; Patra KK; Dhali B; Das N; Barui G
    J Obstet Gynaecol; 2011 May; 31(4):298-303. PubMed ID: 21534749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 4 hours magnesium sulfate infusion on fetal heart rate variability and reactivity in a goat model.
    Sameshima H; Ikenoue T; Kamitomo M; Sakamoto H
    Am J Perinatol; 1998; 15(9):535-8. PubMed ID: 9890251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable hemodynamic effects of magnesium sulfate in preeclampsia.
    Scardo JA; Hogg BB; Newman RB
    Am J Obstet Gynecol; 1995 Oct; 173(4):1249-53. PubMed ID: 7485331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial.
    Brookfield KF; Tuel K; Rincon M; Vinson A; Caughey AB; Carvalho B
    Obstet Gynecol; 2020 Dec; 136(6):1190-1194. PubMed ID: 33156201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.